Global Cell And Gene Therapy Supply Chain/Logistics Market
Healthcare Services

Cell And Gene Therapy Supply Chain/Logistics Market Growth Expected to Reach $2.8 Billion by 2030 with 12.1% CAGR

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Cell And Gene Therapy Supply Chain/Logistics Market During 2026–2030?

The cell and gene therapy supply chain/logistics market has experienced significant expansion recently. Forecasts indicate this market will grow from $1.58 billion in 2025 to $1.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.2%. Historically, this expansion has been driven by factors such as the increasing complexity of cell and gene therapy logistics, the early adoption of cryogenic shipping solutions, the expansion of centralized manufacturing models, a growing regulatory emphasis on traceability, and the rising utilization of specialized logistics providers.

The cell and gene therapy supply chain/logistics market size is anticipated to undergo substantial growth in the next few years. It is projected to reach $2.81 billion by 2030, expanding at a compound annual growth rate (CAGR) of 12.1%. The forecasted expansion can be attributed to several factors, including the increasing commercialization of personalized therapies, a rising demand for end-to-end supply chain visibility, the enlargement of global therapy distribution networks, the growing adoption of cloud-based logistics platforms, and increased investments in smart cold chain infrastructure. Prominent trends throughout this period will involve the development of integrated cold chain management platforms, the widespread implementation of real-time tracking and traceability systems, a growing reliance on cryogenic logistics solutions, the enhanced integration of patient-centric supply chain models, and a heightened focus on chain of custody compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp

What Underlying Factors Are Accelerating The Growth Of The Cell And Gene Therapy Supply Chain/Logistics Market?

The growing demand for cell and gene therapies is propelling the cell and gene therapy supply chain or logistics market. These therapies represent cutting-edge medical approaches that modify cells or genes to combat illnesses, providing promising solutions for previously incurable conditions. Maintaining the correct temperature and storage conditions for these cell and gene therapies is crucial, a requirement met by supply chain and logistics services that manage everything from their procurement to distribution and storage. Illustratively, in 2023, data from the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, indicated a 10% rise in gene therapies undergoing Phase III clinical trials during Q3 2023, marking the initial quarterly growth since Q3 2022. Consequently, the escalating demand for cell and gene therapies continues to advance the cell and gene therapy supply chain or logistics market.

How Are The Various Segments Of The Cell And Gene Therapy Supply Chain/Logistics Market Categorized?

The cell and gene therapy supply chain/logistics market covered in this report is segmented –

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System

2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution

3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components

4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up

5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

Subsegments:

1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools

2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)

3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization

4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting

5) By Logistics Management System: Route Optimization And Planning, Transportation Management

6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes

7) By Quality Management System: Compliance Tracking, Quality Assurance And Control

8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation

How Are Trends Transforming The Cell And Gene Therapy Supply Chain/Logistics Market Landscape?

The growing embrace of modern technology platforms stands out as a key development gaining traction in the cell and gene therapy supply chain/logistics markets. Prominent companies within this sector are creating sophisticated technology platforms for cell and gene therapies to safeguard their market position. For instance, in April 2023, AmerisourceBergen Corporation., a US-based healthcare firm specializing in cell and gene therapy supply chain logistics, launched the Cell and Gene Therapy (CGT) Integration Hub. The Cell and Gene Therapy (CGT) Integration Hub is powered by AmerisourceBergen’s cutting-edge customer relationship management (CRM) system. It offers integration into biopharma platforms, thereby improving the monitoring of cell and gene therapy development and delivery.

Which Major Firms Influence Developments In The Cell And Gene Therapy Supply Chain/Logistics Market?

Major companies operating in the cell and gene therapy supply chain/logistics market are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

Read the full cell and gene therapy supply chain/logistics market report here:

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Which Region Is Projected To Dominate The Cell And Gene Therapy Supply Chain/Logistics Market During The Forecast Period?

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2025. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell And Gene Therapy Supply Chain/Logistics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12631&type=smp

Browse Through More Reports Similar to the Global Cell And Gene Therapy Supply Chain/Logistics Market 2026, By The Business Research Company

Cell And Gene Therapy Manufacturing Services Market

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-manufacturing-services-market

Cell And Gene Therapy Supply Chain Or Logistics Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Global Market Report

https://www.thebusinessresearchcompany.com/report/advanced-therapy-medicinal-products-contract-development-and-manufacturing-organization-cdmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model